GeneDx Holdings(WGS)

133.71-2.09-1.54%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

- GeneDx Launches GenomeDx Prenatal Whole Genome Sequencing for Prenatal Care
  Reuters · 01-07 21:30
  GeneDx Launches GenomeDx Prenatal Whole Genome Sequencing for Prenatal Care
- Super Flu Virus Is Weak Variant, Says Health Minister
  Tempo · 01-07 19:46
  Super Flu Virus Is Weak Variant, Says Health Minister
- GeneDx Appoints Dr. Linda Genen as Chief Medical Officer
  Reuters · 01-06 21:30
  GeneDx Appoints Dr. Linda Genen as Chief Medical Officer
- GeneDx Appoints DR. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care
  THOMSON REUTERS · 01-06 21:30
  GeneDx Appoints DR. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care
- GeneDx Achieves Record Research Milestones with Landmark Rare Disease Genomics Studies in 2025
  Reuters · 01-05 21:30
  GeneDx Achieves Record Research Milestones with Landmark Rare Disease Genomics Studies in 2025
- GeneDx Holdings Is Maintained at Buy by Canaccord Genuity
  Dow Jones · 2025-12-22
  GeneDx Holdings Is Maintained at Buy by Canaccord Genuity
- GeneDx Holdings Corp : Jefferies Raises Target Price to $180 From $150
  THOMSON REUTERS · 2025-12-17
  GeneDx Holdings Corp : Jefferies Raises Target Price to $180 From $150
- GeneDx Holdings Is Maintained at Equal-Weight by Wells Fargo
  Dow Jones · 2025-12-16
  GeneDx Holdings Is Maintained at Equal-Weight by Wells Fargo
- GeneDx Holdings Is Maintained at Buy by BTIG
  Dow Jones · 2025-12-12
  GeneDx Holdings Is Maintained at Buy by BTIG
- Director Joshua Ruch Reports Sale of Genedx Holdings Corp. Common Shares
  Reuters · 2025-11-27
  Director Joshua Ruch Reports Sale of Genedx Holdings Corp. Common Shares
- 6 Healthcare Stocks With Strong Upward Momentum
  Benzinga_recent_news · 2025-11-19
  6 Healthcare Stocks With Strong Upward Momentum
- 3 Stocks Estimated To Be Trading Below Their Intrinsic Value In November 2025
  Simply Wall St. · 2025-11-17
  3 Stocks Estimated To Be Trading Below Their Intrinsic Value In November 2025
- U.S. RESEARCH ROUNDUP-DoorDash, Honeywell, Zscaler
  Reuters · 2025-11-10
  U.S. RESEARCH ROUNDUP-DoorDash, Honeywell, Zscaler
- GeneDx Holdings Corp. to Showcase Genomic Advancements at NSGC Annual Meeting
  Reuters · 2025-11-06
  GeneDx Holdings Corp. to Showcase Genomic Advancements at NSGC Annual Meeting
- GeneDx (WGS): Assessing Valuation After Upbeat Earnings, Raised Guidance, and $100M Equity Offering
  Simply Wall St. · 2025-11-05
  GeneDx (WGS): Assessing Valuation After Upbeat Earnings, Raised Guidance, and $100M Equity Offering
- GeneDx Holdings Is Maintained at Equal-Weight by Wells Fargo
  Dow Jones · 2025-11-05
  GeneDx Holdings Is Maintained at Equal-Weight by Wells Fargo
- William O'Neil Initiates GeneDx Holdings at Buy
  MT Newswires Live · 2025-10-30
  William O'Neil Initiates GeneDx Holdings at Buy
- Stock Track | GeneDx Holdings Soars 5.11% as Multiple Analysts Raise Price Targets
  Stock Track · 2025-10-29
  Stock Track | GeneDx Holdings Soars 5.11% as Multiple Analysts Raise Price Targets
- GeneDx Holdings Is Maintained at Buy by BTIG
  Dow Jones · 2025-10-29
  GeneDx Holdings Is Maintained at Buy by BTIG
- U.S. RESEARCH ROUNDUP-ATI, GoDaddy, Lyft
  Reuters · 2025-10-29
  U.S. RESEARCH ROUNDUP-ATI, GoDaddy, Lyft
Company Profile
Company Name
GeneDx Holdings
Market
NASDAQ
Establishment Date
- -
Employees
- -
Office Location
- -
Website
http://ir.genedx.com
Zip Code
- -
Phone
- -
Fax
- -
Introduction
GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It also provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. is headquartered in Stamford, Connecticut.
- 2025-11-25
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-10-28
  Quarterly Report
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-10-28
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report
- 2025-09-30
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-09-30
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-09-18
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report
- 2025-08-27
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-08-22
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-07-29
  Quarterly Report
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-07-29
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report
- 2025-07-17
  Correspondence
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2025-07-01
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-07-01
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-06-18
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report
- 2025-06-09
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities

1D
5D
Day
Week
Month

Loading ...

High

138.70

Open

136.94

Volume%

0.51

Low

133.71

135.80

T/O Rate

0.57%

To The Moon

GeneDx Holdings(WGS)

Company Profile

Most Discussed